DOCSLIB.ORG

Crystal Structure of the N-Terminal Ankyrin Repeat Domain of TRPV3

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Crystal Structure of the N-Terminal Ankyrin Repeat Domain of TRPV3 Protein Cell 2013, 4(12): 942–950 DOI 10.1007/s13238-013-3091-0 Protein & Cell RESEARCH ARTICLE Crystal structure of the N-terminal ankyrin repeat domain of TRPV3 reveals unique conformation of fi nger 3 loop critical for channel function Di-Jing Shi1*, Sheng Ye2*, Xu Cao1, Rongguang Zhang2, KeWei Wang1,3,4 1 Department of Neurobiology, Neuroscience Research Institute, Peking University Health Science Center, Beijing 100191, China 2 National Laboratory of Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101, China Cell 3 Department of Molecular and Cellular Pharmacology, State Key Laboratory of Natural and Biomimetic Drugs, Peking University & School of Pharmaceutical Sciences, Beijing 100191, China 4 PKU-IDG/McGovern Institute for Brain Research, Peking University, Beijing 100871, China Correspondence: [email protected] (R. Zhang), [email protected] (K. W. Wang) Received August 23, 2013 Accepted October 9, 2013 Protein ABSTRACT of cation channels that function as cellular sensors for numer- ous stimuli (Clapham, 2003). According to their sequence In all six members of TRPV channel subfamily, there is homology, TRP channels are divided into seven subfamilies: an ankyrin repeat domain (ARD) in their intracellular N- TRPV, TRPA, TRPN, TRPM, TRPML, TRPP, and TRPC. termini. Ankyrin (ANK) repeat, a common motif with typi- Among the TRPV subfamily, all six members can be further cally 33 residues in each repeat, is primarily involved divided into two groups: the nonselective and heat-activated in protein-protein interactions. Despite the sequence TRPV1–4 channels primarily expressed in sensory neurons similarity among the ARDs of TRPV channels, the struc- and keratinocytes, and highly Ca2+ selective TRPV5–6 chan- ture of TRPV3-ARD, however, remains unknown. Here, nels primarily expressed in epithelial tissues (Montell et al., we report the crystal structure of TRPV3-ARD solved at 2002; Venkatachalam and Montell, 2007). TRPV1–4 channels 1.95 Å resolution, which reveals six-ankyrin repeats. While are activated by temperature, voltage, protons, and chemicals, overall structure of TRPV3-ARD is similar to ARDs from and are responsible for maintaining homeostasis and sensing other members of TRPV subfamily; it, however, features a environmental changes (Guler et al., 2002; Voets et al., 2004; noticeable fi nger 3 loop that bends over and is stabilized Caterina, 2007; Dhaka et al., 2009). by a network of hydrogen bonds and hydrophobic pack- TRPV3 can be activated by warm temperature with the ing, instead of being fl exible as seen in known TRPV-ARD threshold about 33°C. TRPV3-knockout mice have deficits structures. Electrophysiological recordings demonstrated in response to innocuous and noxious heat, suggesting the that mutating key residues R225, R226, Q255, and F249 of participation of TRPV3 in thermosensation and nociception fi nger 3 loop altered the channel activities and pharmacol- (Moqrich et al., 2005). Like other TRPV channels, TRPV3 is ogy. Taken all together, our findings show that TRPV3- a multimodal cation channel, and can be activated by natural ARD with characteristic fi nger 3 loop likely plays an im- compounds such as camphor, thymol (Moqrich et al., 2005; portant role in channel function and pharmacology. Xu et al., 2006), endogenou s ligands farnesyl pyrophos- phate (FPP), NO (Yoshida et al., 2006; Bang et al., 2010), and KEYWORDS TRPV3, ARD, keratinocyte, 2-APB, skin a synthetic small molecules 2-APB (Chung et al., 2004a; Hu et al., 2004, 2009). TRPV3 has two distinct features. First, both in native and expression systems, TRPV3 does not desensitize INTRODUCTION in response to repetitive stimulations (Chung et al., 2004a, Transient receptor potential (TRP) channels are a large family 2004b). This property is independent of the stimuli (Moqrich *These authors contributed equally to the work. 942 | December 2013 | Volume 4 | Issue 12 © Higher Education Press and Springer-Verlag Berlin Heidelberg 2013 Crystal structure of TRPV3-ARD RESEARCH ARTICLE et al., 2005) and is thought to result from sequential reduction structure of TRPV3-ARD with molecular replacement by using of calcium inhibition on TRPV3 from both sides of cells, likely the structure of rTRPV1-ARD (PDB entry: 2PNN) as a search- because of conformational changes that occur during succes- ing model. In the fi nal model of TRPV3-ARD, there are two sive activation of channel (Xiao et al., 2008a). Second, TRPV3 protein molecules in one asymmetric unit (ASU), which do not is abundantly expressed in the keratinocytes of skin contain- dimerize due to the lack of suffi cient interactions. The overall ing nerve endings that are physiologically required to respond crystal structure of TRPV3-ARD reveals a common feature of to physical and chemical stimuli. Consistent with its specific six ankyrin (ANK) repeats with each repeat consisting of a pair localization, TRPV3 plays critical roles in skin physiology and of anti-parallel α-helices and a loop linking the adjacent repeats pathology. TRPV3 knockout mice exhibit wavy hair and curled (Fig. 1B). Since the inner helices pack more tightly than the whiskers (Cheng et al., 2010), likely resulting from misaligned outer helices, the six repeats stack with a slight counterclock- and curved follicles with deranged angles. wise twist of about 2–3° along the stacking axis. The overall TRP channels are assumed to function as tetramers with structure forms the shape of a palm up with outward projecting each subunit containing six transmembrane helices and in- loops as fi ngers 1–5 (Fig. 1B). A groove is formed by concave tracellular N- and C-termini. In the TRPV subfamily, all the six surface of the palm, which can function as binding sites of in- members share conserved ankyrin repeat domains (ARDs) in teracting proteins (Fig. 1B). their N-termini. These ankyrin repeats are involved in protein- TRPV3-ARD shares overall folds with other TRPV-ARD protein interactions (Stokes et al., 2005; Kim et al., 2006), structures, consistent with their high sequence homology channel assembly (Chang et al., 2004; Erler et al., 2004), and among the ARDs of this subfamily. However, several distinct traffi cking (Arniges et al., 2006). Visualizing the ARDs of TRPV structural features are noted. The most striking variance occurs Cell channels is critical for understanding their molecular basis of at fi nger 3 that bends over towards fi nger 2 and is stabilized by channel function and regulatory mechanisms. The ARD struc- interactions with inner helix of repeat 3 (Fig. 1C). Other struc- & tures, with or without ATP binding, of several TRPV channels tural differences reside in fi nger 4 and 5 near the outer helices, have been reported, including TRPV1, TRPV2, TRPV4, and where these two fingers are two- and four-residue shorter, TRPV6 (Jin et al., 2006; McCleverty et al., 2006; Lishko et al., respectively, in the sequence of TRPV3-ARD, as compared 2007; Phelps et al., 2008; Auer-Grumbach et al., 2010; Inada to TRPV1-ARD. Also, a sequence insertion in TRPV3-ARD Protein et al., 2012). All these structures show that TRPV-ARD con- causes the loop between outer helix 1 and inner helix 2 to be tains six ankyrin repeats with each repeat having an anti-paral- much longer than that of TRPV1-ARD (Fig. 1C). Because the lel helix-turn-helix fold followed by a β-hairpin loop connecting fi ngers may function as binding sites in ankyrin groove, these adjacent repeats. The overall fold forms a hand-up shape with differences suggest the divergence of interacting proteins of the helices as a curved palm and outward projecting loops as different TRPV-ARDs. fi ngers. Compared with classical ankyrin repeats, TRPV-ARDs have obvious twists between repeats 4 and 5. In spite of high The conformation of TRPV3-ARD fi nger 3 similarities in overall folds, TRPV-ARDs have apparent differ- ences in hydrophobic surfaces that mediate interactions with To understand the characteristic conformation of finger 3 in regulatory factors (Phelps et al., 2008; Inada et al., 2012). Until TRPV3-ARD, we made a comparison with previously reported now, however, there is no structural information for TRPV3- TRPV-ARD structures in which three of them are in com- ARD or other domains available for structural insights into mo- plex with ATP (rTRPV1-ARD, cTRPV4-ARD, and hTRPV4- lecular basis of TRPV3 channel function. ARD) and four are ligand-free (rTRPV2-ARD, hTRPV2-ARD, In this study, we solved the crystal structure of TRPV3-ARD hTRPV4-ARD, and mTRPV6-ARD). Since all TRPV-ARD at 1.95 Å resolution. The structural analysis of TRPV3-ARD re- structures share common ANK repeats, the r.m.s.d. among veals six-ankyrin repeats with a long fi nger 3 loop that differen- them is in the range of 1 .4–1.8 Å for backbone Cαs. However, tiates itself from known ARDs of TRPV channels. Patch clamp signifi cant variation in fi nger 3 conformations suggests that the recordings of TRPV3 mutated in key residues of fi nger 3 loop loop is the most fl exible region of TRPV-ARDs (Fig. 2A). Most confi rmed the role of TRPV3-ARD with characteristic fi nger 3 fi nger 3 of TRPV-ARDs bear higher B-factors than their adja- in channel function and pharmacology. cent helical regions (Fig. 2B). In fact, the fi nger 3 of TRPV2- ARD even adopts three different conformations in three dif- RESULTS ferent crystal forms, showing its remarkable fl exibility (Jin et al., 2006). With or without ATP binding, most fi nger 3 have no Overall structure of TRPV3-ARD direct interactions with the helices of ANK repeats. The mTRPV3-ARD proteins containing residues 118 to 367 Unlike other TRPV-ARDs, the fi nger 3 of both TRPV3-ARD were expressed and purifi ed from Rosetta (DE3) with affi nity molecules in one ASU bends over and forms a unique con- an d size exclusion chromatography (SEC).
Load more

Recommended publications
  • Ankrd9 Is a Metabolically-Controlled Regulator of Impdh2 Abundance and Macro-Assembly
    ANKRD9 IS A METABOLICALLY-CONTROLLED REGULATOR OF IMPDH2 ABUNDANCE AND MACRO-ASSEMBLY by Dawn Hayward A dissertation submitted to The Johns Hopkins University in conformity with the requirements of the degree of Doctor of Philosophy Baltimore, Maryland April 2019 ABSTRACT Members of a large family of Ankyrin Repeat Domains proteins (ANKRD) regulate numerous cellular processes by binding and changing properties of specific protein targets. We show that interactions with a target protein and the functional outcomes can be markedly altered by cells’ metabolic state. ANKRD9 facilitates degradation of inosine monophosphate dehydrogenase 2 (IMPDH2), the rate-limiting enzyme in GTP biosynthesis. Under basal conditions ANKRD9 is largely segregated from the cytosolic IMPDH2 by binding to vesicles. Upon nutrient limitation, ANKRD9 loses association with vesicles and assembles with IMPDH2 into rod-like structures, in which IMPDH2 is stable. Inhibition of IMPDH2 with Ribavirin favors ANKRD9 binding to rods. The IMPDH2/ANKRD9 assembly is reversed by guanosine, which restores association of ANKRD9 with vesicles. The conserved Cys109Cys110 motif in ANKRD9 is required for the vesicles-to-rods transition as well as binding and regulation of IMPDH2. ANKRD9 knockdown increases IMPDH2 levels and prevents formation of IMPDH2 rods upon nutrient limitation. Thus, the status of guanosine pools affects the mode of ANKRD9 action towards IMPDH2. Advisor: Dr. Svetlana Lutsenko, Department of Physiology, Johns Hopkins University School of Medicine Second reader:
    [Show full text]
  • Repeat Proteins Challenge the Concept of Structural Domains
    844 Biochemical Society Transactions (2015) Volume 43, part 5 Repeat proteins challenge the concept of structural domains Rocıo´ Espada*1, R. Gonzalo Parra*1, Manfred J. Sippl†, Thierry Mora‡, Aleksandra M. Walczak§ and Diego U. Ferreiro*2 *Protein Physiology Lab, Dep de Qu´ımica Biologica, ´ Facultad de Ciencias Exactas y Naturales, UBA-CONICET-IQUIBICEN, Buenos Aires, C1430EGA, Argentina †Center of Applied Molecular Engineering, Division of Bioinformatics, Department of Molecular Biology, University of Salzburg, 5020 Salzburg, Austria ‡Laboratoire de physique statistique, CNRS, UPMC and Ecole normale superieure, ´ 24 rue Lhomond, 75005 Paris, France §Laboratoire de physique theorique, ´ CNRS, UPMC and Ecole normale superieure, ´ 24 rue Lhomond, 75005 Paris, France Abstract Structural domains are believed to be modules within proteins that can fold and function independently. Some proteins show tandem repetitions of apparent modular structure that do not fold independently, but rather co-operate in stabilizing structural forms that comprise several repeat-units. For many natural repeat-proteins, it has been shown that weak energetic links between repeats lead to the breakdown of co-operativity and the appearance of folding sub-domains within an apparently regular repeat array. The quasi-1D architecture of repeat-proteins is crucial in detailing how the local energetic balances can modulate the folding dynamics of these proteins, which can be related to the physiological behaviour of these ubiquitous biological systems. Introduction and between repeats, challenging the concept of structural It was early on noted that many natural proteins typically domain. collapse stretches of amino acid chains into compact units, defining structural domains [1]. These domains typically correlate with biological activities and many modern proteins can be described as composed by novel ‘domain arrange- Definition of the repeat-units ments’ [2].
    [Show full text]
  • A Structural Guide to Proteins of the NF-Kb Signaling Module
    Downloaded from http://cshperspectives.cshlp.org/ on September 26, 2021 - Published by Cold Spring Harbor Laboratory Press A Structural Guide to Proteins of the NF-kB Signaling Module Tom Huxford1 and Gourisankar Ghosh2 1Department of Chemistry and Biochemistry, San Diego State University, 5500 Campanile Drive, San Diego, California 92182-1030 2Department of Chemistry and Biochemistry, University of California, San Diego, 9500 Gilman Drive, La Jolla, California 92093-0375 Correspondence: [email protected] The prosurvival transcription factor NF-kB specifically binds promoter DNA to activate target gene expression. NF-kB is regulated through interactions with IkB inhibitor proteins. Active proteolysis of these IkB proteins is, in turn, under the control of the IkB kinase complex (IKK). Together, these three molecules form the NF-kB signaling module. Studies aimed at charac- terizing the molecular mechanisms of NF-kB, IkB, and IKK in terms of their three-dimen- sional structures have lead to a greater understanding of this vital transcription factor system. F-kB is a master transcription factor that from the perspective of their three-dimensional Nresponds to diverse cell stimuli by activat- structures. ing the expression of stress response genes. Multiple signals, including cytokines, growth factors, engagement of the T-cell receptor, and NF-kB bacterial and viral products, induce NF-kB Introduction to NF-kB transcriptional activity (Hayden and Ghosh 2008). A point of convergence for the myriad NF-kB was discovered in the laboratory of of NF-kB inducing signals is the IkB kinase David Baltimore as a nuclear activity with bind- complex (IKK). Active IKK in turn controls ing specificity toward a ten-base-pair DNA transcription factor NF-kB by regulating pro- sequence 50-GGGACTTTCC-30 present within teolysis of the IkB inhibitor protein (Fig.
    [Show full text]
  • Supp. Table S2: Domains and Protein Families with a Putative Role in Host-Symbiont Interactions
    Supp. Table S2: Domains and protein families with a putative role in host-symbiont interactions. The domains and protein families listed here were included in the comparisons in Figure 5 and Supp. Figure S5, which show the percentage of the respective protein groups in the Riftia symbiont metagenome and in metagenomes of other symbiotic and free-living organisms. % bacterial, total number bacterial: Percentage and total number of bacterial species in which this domain is found in the SMART database (January 2019). Domain name Pfam/SMART % bacterial (total Literature/comment annotation number bacterial) Alpha-2- alpha-2- A2M: 42.05% (2057) A2Ms: protease inhibitors which are important for eukaryotic macroglobulin macroglobulin innate immunity, if present in prokaryotes apparently fulfill a family (A2M), similar role, e.g. protection against host proteases (1) including N- terminal MG1 domain ANAPC Anaphase- APC2: 0 Ubiquitin ligase, important for cell cycle control in eukaryotes (2) promoting complex Bacterial proteins might interact with ubiquitination pathways in subunits the host (3) Ankyrin Ankyrin repeats 10.88% (8348) Mediate protein-protein interactions without sequence specificity (4) Sponge symbiont ankyrin-repeat proteins inhibit amoebal phagocytosis (5) Present in sponge microbiome metatranscriptomes, putative role in symbiont-host interactions (6) Present in obligate intracellular amoeba symbiont Candidatus Amoebophilus asiaticus genome, probable function in interactions with the host (7) Armadillo Armadillo repeats 0.83% (67)
    [Show full text]
  • Appendix 2. Significantly Differentially Regulated Genes in Term Compared with Second Trimester Amniotic Fluid Supernatant
    Appendix 2. Significantly Differentially Regulated Genes in Term Compared With Second Trimester Amniotic Fluid Supernatant Fold Change in term vs second trimester Amniotic Affymetrix Duplicate Fluid Probe ID probes Symbol Entrez Gene Name 1019.9 217059_at D MUC7 mucin 7, secreted 424.5 211735_x_at D SFTPC surfactant protein C 416.2 206835_at STATH statherin 363.4 214387_x_at D SFTPC surfactant protein C 295.5 205982_x_at D SFTPC surfactant protein C 288.7 1553454_at RPTN repetin solute carrier family 34 (sodium 251.3 204124_at SLC34A2 phosphate), member 2 238.9 206786_at HTN3 histatin 3 161.5 220191_at GKN1 gastrokine 1 152.7 223678_s_at D SFTPA2 surfactant protein A2 130.9 207430_s_at D MSMB microseminoprotein, beta- 99.0 214199_at SFTPD surfactant protein D major histocompatibility complex, class II, 96.5 210982_s_at D HLA-DRA DR alpha 96.5 221133_s_at D CLDN18 claudin 18 94.4 238222_at GKN2 gastrokine 2 93.7 1557961_s_at D LOC100127983 uncharacterized LOC100127983 93.1 229584_at LRRK2 leucine-rich repeat kinase 2 HOXD cluster antisense RNA 1 (non- 88.6 242042_s_at D HOXD-AS1 protein coding) 86.0 205569_at LAMP3 lysosomal-associated membrane protein 3 85.4 232698_at BPIFB2 BPI fold containing family B, member 2 84.4 205979_at SCGB2A1 secretoglobin, family 2A, member 1 84.3 230469_at RTKN2 rhotekin 2 82.2 204130_at HSD11B2 hydroxysteroid (11-beta) dehydrogenase 2 81.9 222242_s_at KLK5 kallikrein-related peptidase 5 77.0 237281_at AKAP14 A kinase (PRKA) anchor protein 14 76.7 1553602_at MUCL1 mucin-like 1 76.3 216359_at D MUC7 mucin 7,
    [Show full text]
  • WSB1: from Homeostasis to Hypoxia Moinul Haque1,2,3, Joseph Keith Kendal1,2,3, Ryan Matthew Macisaac1,2,3 and Douglas James Demetrick1,2,3,4*
    Haque et al. Journal of Biomedical Science (2016) 23:61 DOI 10.1186/s12929-016-0270-3 REVIEW Open Access WSB1: from homeostasis to hypoxia Moinul Haque1,2,3, Joseph Keith Kendal1,2,3, Ryan Matthew MacIsaac1,2,3 and Douglas James Demetrick1,2,3,4* Abstract The wsb1 gene has been identified to be important in developmental biology and cancer. A complex transcriptional regulation of wsb1 yields at least three functional transcripts. The major expressed isoform, WSB1 protein, is a substrate recognition protein within an E3 ubiquitin ligase, with the capability to bind diverse targets and mediate ubiquitinylation and proteolytic degradation. Recent data suggests a new role for WSB1 as a component of a neuroprotective pathway which results in modification and aggregation of neurotoxic proteins such as LRRK2 in Parkinson’s Disease, via an unusual mode of protein ubiquitinylation. WSB1 is also involved in thyroid hormone homeostasis, immune regulation and cellular metabolism, particularly glucose metabolism and hypoxia. In hypoxia, wsb1 is a HIF-1 target, and is a regulator of the degradation of diverse proteins associated with the cellular response to hypoxia, including HIPK2, RhoGDI2 and VHL. Major roles are to both protect HIF-1 function through degradation of VHL, and decrease apoptosis through degradation of HIPK2. These activities suggest a role for wsb1 in cancer cell proliferation and metastasis. As well, recent work has identified a role for WSB1 in glucose metabolism, and perhaps in mediating the Warburg effect in cancer cells by maintaining the function of HIF1. Furthermore, studies of cancer specimens have identified dysregulation of wsb1 associated with several types of cancer, suggesting a biologically relevant role in cancer development and/or progression.
    [Show full text]
  • Structural and Biochemical Consequences of Disease-Causing Mutations in the Ankyrin Repeat Domain of the Human TRPV4 Channel
    Structural and Biochemical Consequences of Disease-Causing Mutations in the Ankyrin Repeat Domain of the Human TRPV4 Channel The Harvard community has made this article openly available. Please share how this access benefits you. Your story matters Citation Inada, Hitoshi, Erik Procko, Marcos Sotomayor, and Rachelle Gaudet. 2012. Structural and biochemical consequences of disease- causing mutations in the ankyrin repeat domain of the human TRPV4 channel. Biochemistry 51(31): 6195-6206. Published Version doi:10.1021/bi300279b Citable link http://nrs.harvard.edu/urn-3:HUL.InstRepos:11688820 Terms of Use This article was downloaded from Harvard University’s DASH repository, and is made available under the terms and conditions applicable to Other Posted Material, as set forth at http:// nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of- use#LAA Structural and biochemical consequences of disease-causing mutations in the ankyrin repeat domain of the human TRPV4 channel Hitoshi Inada†, Erik Procko†,‡, Marcos Sotomayor†,§, and Rachelle Gaudet†,* †Department of Molecular and Cellular Biology, Harvard University, 52 Oxford Street, Cambridge, MA 02138 ‡Present address: Howard Hughes Medical Institute and Department of Biochemistry, University of Washington, Seattle, WA 98195, USA §Howard Hughes Medical Institute and Department of Neurobiology, Harvard Medical School, Boston, MA 02115, USA AUTHOR EMAIL ADDRESS: [email protected] TITLE RUNNING HEAD: Structural analysis of human TRPV4-ARD CORRESPONDING AUTHOR FOOTNOTE: *To whom correspondence should be addressed: Rachelle Gaudet, Department of Molecular and Cellular Biology, Harvard University, 52 Oxford Street, Cambridge, MA 02138, USA, Tel.: (617) 495-5616; Fax: (617) 496-9684; E-mail: [email protected] FOOTNOTES: This work was funded by NIH grant R01GM081340 to RG.
    [Show full text]
  • Dissecting and Reprogramming the Folding and Assembly of Tandem-Repeat Proteins
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Apollo Dissecting and reprogramming the folding and assembly of tandem-repeat proteins Pamela J.E. Rowling1, Elin M. Sivertsson1, Albert Perez-Riba1, Ewan R. G. Main2*, Laura S. Itzhaki1* 1University of Cambridge Department of Pharmacology, Tennis Court Road, Cambridge CB2 1PD, UK. 2School of Biological and Chemical Sciences, Queen Mary, University of London, London E1 4NS, UK. *To whom correspondence should be addressed: [email protected] and [email protected] Studying protein folding and protein design in globular proteins presents significant challenges because of the two related features, topological complexity and cooperativity. In contrast, tandem-repeat proteins have regular and modular structures composed of linearly arrayed motifs. This means that the biophysics of even giant repeat proteins is highly amenable to dissection and to rational design. Here we discuss what has been learnt about the folding mechanisms of tandem- repeat proteins. The defining features that have emerged are: (i) accessibility of multiple distinct routes between denatured and native states, both at equilibrium and under kinetic conditions; (ii) different routes are favoured for folding versus unfolding; (iii) unfolding energy barriers are broad, reflecting stepwise unraveling of an array repeat by repeat; (iv) highly cooperative unfolding at equilibrium and the potential for exceptionally high thermodynamic stabilities by introducing consensus residues; (v) under force, helical-repeat structures are very weak with non-cooperative unfolding leading to elasticity and buffering effects. This level of understanding should enable us to create repeat proteins with made-to-measure folding mechanisms, in which one can dial into the sequence the order of repeat folding, number of pathways taken, step size (cooperativity) and fine-structure of the kinetic energy barriers.
    [Show full text]
  • Take Home Lessons from Studies of Related Proteins
    Available online at www.sciencedirect.com Take home lessons from studies of related proteins * Adrian A Nickson, Beth G Wensley and Jane Clarke The ‘Fold Approach’ involves a detailed analysis of the folding The malleability of protein folding pathways of several topologically, structurally and/or evolutionarily A unifying folding mechanism related proteins. Such studies can reveal determinants of the In the early days of the ‘protein-folding problem’, three folding mechanism beyond the gross topology, and can dissect competing mechanisms were proposed that described the residues required for folding from those required for stability how a polypeptide chain might fold to the native state: or function. While this approach has not yet matured to the nucleation [3], hydrophobic-collapse [4] and diffusion- point where we can predict the native conformation of any collision (framework) [5]. However, an early F-value polypeptide chain in silico, it has been able to highlight, analysis of the small protein chymotrypsin inhibitor 2 amongst others, the specific residues that are responsible for (CI2) demonstrated that none of these mechanisms was nucleation, pathway malleability, kinetic intermediates, chain appropriate, since secondary and tertiary structure formed knotting, internal friction and Paracelsus switches. Some of the concomitantly [6]. Thus the nucleation-condensation most interesting discoveries have resulted from the attempt to mechanism was introduced [7], in which long-range con- explain differences between homologues. tacts set up the initial topology of the protein (incurring a Address substantial entropic loss with minimal enthalpic gain), Department of Chemistry, University of Cambridge, Lensfield Rd, followed by a rapid collapse to the native state (with Cambridge CB2 1EW, UK minimal entropic loss but substantial enthalpic gain).
    [Show full text]
  • (TRP) Cation Channels Could Explain Smell, Taste, And/Or Chemesthesis Disorders
    Interactions of SARS-CoV-2 spike protein and transient receptor potential (TRP) cation channels could explain smell, taste, and/or chemesthesis disorders Halim Maaroufi Institut de biologie intégrative et des systèmes (IBIS). Université Laval. Quebec city, Quebec, Canada. [email protected] IN BRIEF SARS-CoV-2 S protein contains two ankyrin repeat binding motifs (S-ARBMs) that could interact with ankyrin repeat domains (ARDs) of transient receptor potential (TRP) channels. The latter play a role in olfaction, taste, and/or chemesthesis (OTC), suggesting that their dysfunction by S protein could explain OTC disorders in COVID-19 disease. Pharmacological manipulation of TRPs-ARDs could be used for prophylactic or treatments in SARS-CoV-2 infections. HIGHLIGHTS SARS-CoV-2 infection is associated to olfactory, taste, and/or chemesthesis (OTC) disorders (OTCD). Transient receptor potential (TRP) channels play a role in OTC. S protein contains ARBMs that could interact with ARDs of TRPs, thus inducing OTCD. TRPs ligands as possible preventive treatments against COVID-19. KEYWORDS Loss, Olfactory, Taste, Chemesthesis, SARS-CoV-2, S protein, Ankyrin repeat, Ankyrin repeat binding motif, TRPA1, TRPCs, TRPVs, TRPs ligands, DARPins ABBREVIATIONS SARS-CoV-2: severe acute respiratory syndrome coronavirus 2 COVID-19: Coronavirus disease-2019 S protein: Spike protein 1 RBD: Receptor binding domain HR1: Heptad repeat 1 OTC: olfactory, taste and chemesthesis OTCD: olfactory, taste and/or chemesthesis disorders TRP: Transient receptor potential
    [Show full text]
  • The Contribution of the Ankyrin Repeat Domain of TRPV1 As a Thermal
    bioRxiv preprint doi: https://doi.org/10.1101/641803; this version posted May 19, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. 1 The contribution of the ankyrin repeat 2 domain of TRPV1 as a thermal module 3 4 E. Ladrón-de-Guevara 5 G. E. Rangel-Yescas 6 D. A. Fernández-Velasco 7 A. Torres-Larios 8 T. Rosenbaum 9 L. D. Islas 10 11 Abstract 12 The TRPV1 cation non-selective ion channel plays an essential role in thermosensation and perception of 13 other noxious stimuli. TRPV1 can be activated by low pH, high temperature or naturally occurring 14 pungent molecules such as allicin, capsaicin or resiniferatoxin. Its noxious thermal sensitivity makes it an 15 important participant as a thermal sensor in mammals. However, details of the mechanism of channel 16 activation by increases in temperature remain unclear. Here we used a combination of approaches to try 17 to understand the role of the ankyrin repeat domain (ARD) in channel behavior. First, a computational 18 modeling approach by coarse-grained molecular dynamics simulation of the whole TRPV1 embedded in 19 a phosphatidylcholine (POPC) and phosphatidylethanolamine (POPE) membrane provides insight into 20 the dynamics of this channel domain. Global analysis of the structural ensemble shows that the ankyrin 21 repeat domain is a region that sustains high fluctuations during dynamics at different temperatures. We 22 then performed biochemical and thermal stability studies of the purified ARD by means of circular 23 dichroism and tryptophan fluorescence and demonstrate that this region undergoes structural changes 24 at similar temperatures that lead to TRPV1 activation.
    [Show full text]
  • Use of Protein Engineering Techniques to Elucidate Protein Folding Pathways
    Provided for non-commercial research and educational use only. Not for reproduction, distribution or commercial use. This chapter was originally published in the book Progress in Molecular Biology and Translational Science, Vol. 84, published by Elsevier, and the attached copy is provided by Elsevier for the author's benefit and for the benefit of the author's institution, for non-commercial research and educational use including without limitation use in instruction at your institution, sending it to specific colleagues who know you, and providing a copy to your institution’s administrator. All other uses, reproduction and distribution, including without limitation commercial reprints, selling or licensing copies or access, or posting on open internet sites, your personal or institution’s website or repository, are prohibited. For exceptions, permission may be sought for such use through Elsevier's permissions site at: http://www.elsevier.com/locate/permissionusematerial From: Anna L. Mallam and Sophie E. Jackson, Use of Protein Engineering Techniques to Elucidate Protein Folding Pathways. In P. Michael Conn, editor: Progress in Molecular Biology and Translational Science, Vol. 84, Burlington: Academic Press, 2008, pp. 57-113. ISBN: 978-0-12-374595-8 © Copyright 2008 Elsevier Inc. Academic Press. Author's personal copy Use of Protein Engineering Techniques to Elucidate Protein Folding Pathways Anna L. Mallam and Sophie E. Jackson Department of Chemistry, Cambridge, CB2 1EW, United Kingdom I. Introduction............................................................................... 58 II. Early Protein Engineering Studies of Folding Pathways ........................ 59 III. Single Point Mutations and F‐Value Analysis...................................... 61 A. Mixed a/b Proteins .................................................................. 65 B. All‐a‐Helical Proteins............................................................... 69 C. All‐b‐Proteins........................................................................
    [Show full text]